Navigation Links
Lifecycle Biotechnologies Completes Full Integration of Chata Biosystems and VI Plastics
Date:1/2/2020

With the integration, the company will continue to provide custom and semi-custom aqueous reagents, chemicals, and medias, as well as medical grade plastic products to the world’s leading pharmaceutical, medical device, biologics, diagnostics, cellular agriculture, and cell- and tissue-based product manufacturers.

“We are excited to bring even more advantages and convenience to our partners and supply chain,” said Cody Yarborough, CEO for Lifecycle Biotechnologies. “By operating under one company, we will simplify partner ordering and logistics without compromising the superior quality of our products and manufacturing processes.”

Lifecycle’s integration efforts will provide partners with more and enhanced product offerings under a unified marketing message. It will also align the way Lifecycle operates internally around its four major market divisions; Biopharmaceuticals, Cellular Agriculture, Industrial, and Regenerative Medicine. As these divisions continue to evolve, Lifecycle will be positioned at the forefront with its innovative products and industry relevant subject matter experts. The integration will also provide a higher and more intimate level of service across the organization to its partner base.

This is a natural evolution for the company since all brands will now be fully integrated. Following is a listing of the major changes that are part of this integration:

New legal name for Chata Biosystems and VI Plastics

Both Chata Biosystems and VI Plastics have officially changed their names to Lifecycle Biotechnologies, LP. This is a change in name and not a change in ownership. The products, the staff, and the facilities will remain the same.
Supplier qualification/requalification process

The name change may require that Lifecycle is set up as a new vendors. Lifecycle will do all it possibly can to support this activity. Lifecycle’s Quality Department personnel are available to provide information or to help in completing the supplier qualification paperwork.

ISO certificates

Lifecycle’s current ISO9001 and ISO13485 certificates already reflect Lifecycle Biotechnologies. Copies of these certificates can be download from their website at ISO9001 and ISO13485.

Packaging and documents

Chata Biosystems and VI Plastics will be utilizing the Lifecycle Biotechnologies name on all Packaging, COAs, SDSs, Quotes, Invoices, Packing Lists and all other documents. All documentation will show the Lifecycle Biotechnologies name and logo. It is possible during this transition that partners may see a Chata or VI Plastics logo on something, but by the end of Q1 2020 this should no longer occur.

Remit to address

As part of this integration Lifecycle is streamlining all accounting correspondence through their Fort Worth, Texas facility. Lifecycle will also be updating their banking information to align with the integration. This pertains to their partners remitting payment against invoices, or their vendors issuing invoices. The address to use for all accounting correspondence is:

Lifecycle Biotechnologies
Attn: Accounting
425 Houston Street, Suite 550
Fort Worth, TX 76102

Contact Lifecycle by e-mail at info@lifecyclebio.com, call them at 817.840.7855, or chat with them at http://www.lifecyclebio.com for help, further information, or for details pertaining to banking accounts and wire transfers.

Lifecycle understand that these types of changes are often a little burdensome; and asks for patience as they move closer to combining all of our services within one Lifecycle to give their partners seamless access to all of their products. As they prepare for the next decade with a vision for the future, Lifecycle Biotechnologies looks forward to continued excellence and expansion.

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for over 40 years. Lifecycle’s products are the beginning of the lifecycle of the lifesaving and life-enhancing medical products used globally today. As a leading life sciences tools and service supplier, Lifecycle fully understands the critical role its products play in many of the world’s leading pharmaceuticals, medical devices, biologics, diagnostics, cellular agriculture, cell- and tissue-based products, and many other medical products. While Lifecycle’s products aren’t used to diagnose, treat, or cure patients, without their contribution, none of this would be possible.

Read the full story at https://www.prweb.com/releases/lifecycle_biotechnologies_completes_full_integration_of_chata_biosystems_and_vi_plastics/prweb16799597.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. William Muzek joins Lifecycle Biotechnologies as Business Development Manager
2. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
3. Lifecycle Biotechnologies Releases Company Catalog
4. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
5. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
6. Lifecycle Biotechnologies Announces Cellular Agriculture Expansion
7. Lifecycle Biotechnologies launches second generation CHEM+POUR Bag
8. Evonik Industries Selects OPX Biotechnologies for Joint Development of Bio-Based Chemicals
9. Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A
10. International team completes systematic, genomic study of cervical cancer
11. HITLAB Completes GCP Audit for FDA Smart Device & App Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... August 25, 2020 , ... Modality Solutions, ... magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking of ... as well, and for this year’s list, reported three-year revenue growth of 71 percent. ...
(Date:8/21/2020)... Rochelle, Virginia (PRWEB) , ... August 20, 2020 ... ... announced today that Hassan Movahhed , a Clinical Operations executive with expertise ... CRO management, has joined the firm as an Expert Consultant. Throughout his career, ...
(Date:8/5/2020)... ... 2020 , ... Regenative Labs has received approval from the Centers for Medicare ... the first Wharton’s jelly allografts to be assigned a Q code and be approved ... first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... eSource has long been touted as the solution to high ... eSource, the reasons it did not take off as quickly as people initially expected, ... is moving towards capturing data electronically for clinical trials and then repurposing it for ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... solutions to aid in the early detection and prevention of high-burden diseases, and ... enable US-based hospitals and healthcare organizations to utilize existing data in order to ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
Breaking Biology Technology: